LeonaBio (LONA) Capital Expenditures (2020 - 2024)
LeonaBio (LONA) reported Capital Expenditures of $28000.0 for Q2 2024, down 15.15% year-over-year from $33000.0 in Q3 2023, and up 460.0% quarter-over-quarter from $5000.0 in Q1 2024.
LeonaBio (LONA) Capital Expenditures (2020 - 2024) Analysis & Trends
LeonaBio (LONA) has 5 years of Capital Expenditures data on file, last reported at $28000.0 in Q2 2024.
- Capital Expenditures for Q2 2024 came in at $28000.0, down 15.15% year-over-year; the trailing twelve-month figure through Dec 2024 was $33000.0 (down 89.14% YoY), and the FY2024 annual result was $33000.0, down 89.14% from the prior year.
- Capital Expenditures improved to $28000.0 in Q2 2024 per LONA's latest filing, from $5000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.0 million in Q4 2021 and troughed at $1000.0 in Q4 2022.
- A 5-year average of $236928.6 and a median of $139500.0 in 2021 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2021 and 2022: Capital Expenditures jumped 286.09% in 2021, then sank 99.9% in 2022.
- A 5-year view of Capital Expenditures shows it stood at $266000.0 in 2020, then jumped by 286.09% to $1.0 million in 2021, then slumped by 99.9% to $1000.0 in 2022, then surged by 2900.0% to $30000.0 in 2023, then decreased by 6.67% to $28000.0 in 2024.
- Business Quant data shows LONA's Capital Expenditures at $28000.0 in Q2 2024, $5000.0 in Q1 2024, and $30000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 241,000.00 |
| Mar 31, 2023 | 241,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 244,000.00 |
| Sep 30, 2022 | 244,000.00 |
| Jun 30, 2022 | 151,000.00 |
| Jun 30, 2022 | 151,000.00 |
| Mar 31, 2022 | 745,000.00 |
| Mar 31, 2022 | 745,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Dec 31, 2021 | 1.03 Mn |